Lifecome Biochemistry Co

Lifecome Biochemistry Co Current Liabilities

The Current Liabilities of Lifecome Biochemistry Co (002868.SZ) as of Oct 29, 2026 is 775.74 M CNY. In the previous year, Current Liabilities was 1.84 B CNY — a change of -57.85% (lower).

Current Liabilities

775.74 MCNY

YoY

-57.85%

Last updated:

Current Liabilities of Lifecome Biochemistry Co is 2025 775.74 M CNY. Current Liabilities of Lifecome Biochemistry Co was 2024 1.84 B CNY. It decreases by -57.85% lower compared to the previous year.

The Lifecome Biochemistry Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
56.46 M CNY
Jan 1, 2019
152.76 M CNY
Jan 1, 2020
149.37 M CNY
Jan 1, 2021
434.48 M CNY
Jan 1, 2022
567.39 M CNY
Jan 1, 2023
1.16 B CNY
Jan 1, 2024
1.84 B CNY
Jan 1, 2025
775.74 M CNY
The Lifecome Biochemistry Co Current Liabilities history
YEARCurrent LiabilitiesYoY
775.74 MCNY-57.85%
1.84 BCNY+59.01%
1.16 BCNY+103.99%
567.39 MCNY+30.59%
434.48 MCNY+190.88%
149.37 MCNY-2.22%
152.76 MCNY+170.53%
56.46 MCNY-5.72%
59.89 MCNY-33.82%
90.50 MCNY-30.00%
129.28 MCNY-29.16%
182.49 MCNY+5.93%
172.28 MCNY+17.86%
146.17 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifecome Biochemistry Co Stock analysis

What does Lifecome Biochemistry Co do? Lifecome Biochemistry Co., Ltd. generates revenue through the production and sale of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives, and biological pesticides. The company's product portfolio includes bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series, and Jinggangmycin series. These products are distributed domestically and internationally, targeting agricultural and veterinary sectors for animal health and feed enhancement. The firm's primary customers are domestic agricultural enterprises and international buyers seeking veterinary and feed solutions. Veterinary premixes and raw materials are key revenue drivers, alongside biological pesticides used in farming. Food and feed additives cater to the growing demand for safe and efficient animal nutrition products in both local and global markets. Lifecome Biochemistry's sales strategy focuses on leveraging its range of microbial pharmaceuticals, including probiotics and biological pesticides, to serve the agricultural industry. The company's domestic market presence is complemented by overseas distribution, ensuring a steady revenue stream from both regional and international clients. Lifecome Biochemistry Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifecome Biochemistry Co stock

Current Liabilities of Lifecome Biochemistry Co is 775.74 M CNY in 2025.

Current Liabilities of Lifecome Biochemistry Co changed from 1.84 B CNY to 775.74 M CNY, representing a -57.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Lifecome Biochemistry Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Lifecome Biochemistry Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Lifecome Biochemistry Co

All Key Metrics — Lifecome Biochemistry Co